Search Results - "DI POI, E"

Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step‐up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years by Ferraccioli, G. F., Gremese, E., Tomietto, P., Favret, G., Damato, R., Di Poi, E.

“…Objective. To evaluate two monotherapies followed by step‐up combination therapy with two or three complementary drugs in active rheumatoid arthritis (RA) in…”
Get full text

Structured report for chest high-resolution computed tomography in patients with connective tissue disease: Impact on the report quality as perceived by referring clinicians by Cereser, L., Marchesini, F., Di Poi, E., Sacco, S., De Marchi, G., Linda, A., Como, G., Zuiani, C., Girometti, R.

“…•Completeness and clarity are perceived as high in structured HRCT reports of CTD.•Clinicians perceive high clinical relevance in structured HRCT reports of…”
Get full text

Potential transfer of aquatic organisms via ballast water with a particular focus on harmful and non-indigenous species: A survey from Adriatic ports by Cabrini, M., Cerino, F., de Olazabal, A., Di Poi, E., Fabbro, C., Fornasaro, D., Goruppi, A., Flander-Putrle, V., Francé, J., Gollasch, S., Hure, M., Lipej, L., Lučić, D., Magaletti, E., Mozetič, P., Tinta, T., Tornambè, A., Turk, V., Uhan, J., David, M.

“…Ballast water discharges may cause negative impacts to aquatic ecosystems, human health and economic activities by the introduction of potentially harmful…”
Get full text

Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial by Ferraccioli, G. F., Assaloni, R., Di Poi, E., Gremese, E., De Marchi, G., Fabris, M.

“…Objective. To assess the possible clinical and biological rescue of rheumatoid arthritis (RA) in 16 patients who were still active despite intensive…”
Get full text

Structure and interactions within the pelagic microbial food web (from viruses to microplankton) across environmental gradients in the Mediterranean Sea by Di Poi, E., Blason, C., Corinaldesi, C., Danovaro, R., Malisana, E., Fonda-Umani, S.

“…We have investigated here the structure of the pelagic microbial food web and quantified the carbon fluxes from viruses to microplankton along trophic…”
Get full text

Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections by Ferraccioli, G, Mecchia, F, Di Poi, E, Fabris, M

“…Objective: To assess the occurrence of anticardiolipin antibodies (ACA) (as well as of anti-DNA antibodies) in patients with rheumatoid arthritis treated with…”
Get full text

Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis by FABRIS, Martina, DI POI, Emma, D'ELIA, Angela, DAMANTE, Giuseppe, SINIGAGLIA, Luigi, FERRACCIOLI, Gianfranco

“…OBJECTIVE: To examine whether severe rheumatoid arthritis (RA) carries a -238 or +489 tumor necrosis factor-alpha (TNF-alpha) genotype different from…”
Get full text

High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience by De Vita, S, Ferraccioli, G F, Di Poi, E, Bartoli, E, Bombardieri, S

“…The actual efficacy and applicability of high dose intravenous immunoglobulin (IVIG) therapy in the rheumatic disorders is still being debated. In the last few…”
Get more information

Neuropsychological tests, MRI and SPECT in the evaluation of CNS involvement in SLE by Tomietto, P, Annese, V, D'Agostini, S, Gremese, E, Di Poi, E, Ferraccioli, G

“…To assess the agreement between presence and location of central nervous system (CNS) structural damage and neuropsychological performance. 21 unselected SLE…”
Get full text

TNF- alpha gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-alpha agents: preliminary results by Fabris, M, Di Poi, E, Sacco, S, Damante, G, Sinigaglia, L, Ferraccioli, G

“…To study -238 and +489 TNF-alpha polymorphisms in severe-unresponsive (more than 6 swollen joints and still active disease despite at least 6 months of DMARDs…”
Get full text

Neurological involvement in systemic sclerosis. Evidence of a central Raynaud’s phenomenon by Di Poi, E., Bombardieri, M., Damato, R., Gremese, E., Valesini, G., Ferraccioli, GF

“…Objective: To evaluate the neurological involvement in systemic sclerosis and to identify changes of cerebral blood flow after a cold stressor test. Methods:…”
Get full text

Real-world evidence on pulmonary arterial hypertension: interim analysis from the Italian observational study INSPECTIO by D' Alto, M, Scelsi, L, Badagliacca, R, Giuliani, L, Perna, G P, Ameri, P, Baldi, F, Guerra, F, Di Poi, E, Vicenzi, M, Bux, F, Bonsante, E, Uglietti, A, Rucci, F, De Santis, S

“…Abstract Background Pulmonary arterial hypertension (PAH) is a rare, progressive disease leading to right-sided heart failure. The interest in risk assessment…”
Get full text

Response of mononuclear cells to lipopolysaccharide and CpG oligonucleotide stimulation: possible additive effect in rheumatoid inflammation by Tolusso, B, Fabris, M, Di Poi, E, Assaloni, R, Tomietto, P, Ferraccioli, G F

“…[...]it is well known that oligonucleotides containing unmethylated CpG sequences (CpG-ODN), while stimulating bacterial DNA, might have immunostimulatory…”
Get full text

Risk assessment according to the presence of left heart disease phenotype in pulmonary arterial hypertension patients: a multicenter cohort study by Toma, M, Barbisan, D, Lombardi, C M, Airo, E, Driussi, M, Gentile, P, Howard, L, Moschella, M, Di Poi, E, Garascia, A, Adamo, M, Sinagra, G, Lo Giudice, F, Stolfo, D, Ameri, P

“…Abstract Introduction Subclinical left heart disease (LHD) may impact the management of pulmonary arterial hypertension (PAH) [1]. Purpose To evaluate the…”
Get full text

Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study by Ruffatti, Amelia, Salvan, Elisa, Del Ross, Teresa, Gerosa, Maria, Andreoli, Laura, Maina, Aldo, Alijotas-Reig, Jaume, De Carolis, Sara, Mekinian, Arsene, Bertero, Maria Tiziana, Canti, Valentina, Brucato, Antonio, Bremme, Katarina, Ramoni, Véronique, Mosca, Marta, Di Poi, Emma, Caramaschi, Paola, Galeazzi, Mauro, Tincani, Angela, Trespidi, Laura, Meroni, Pier Luigi

“…Previous thrombosis, diagnosis of systemic lupus erythematosus (SLE) and triple antiphospholipid (aPL) antibody positivity have recently been found to be…”
Get more information

IL-6 and some natural inhibitors of chronic human inflammation in RA and SLE by Di Poi, E, Ferraccioli, G F

Get full text

Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension by Stolfo, Davide, Barbisan, Davide, Ameri, Pietro, Lombardi, Carlo Mario, Monti, Simonetta, Driussi, Mauro, Zovatto, Isabella Carlotta, Gentile, Piero, Howard, Luke, Toma, Matteo, Pagnesi, Matteo, Collini, Valentino, Bauleo, Carolina, Guglielmi, Giulia, Adamo, Marianna, D'Angelo, Luciana, Nalli, Chiara, Sciarrone, Paolo, Moschella, Martina, Zorzi, Barbara, Vecchiato, Veronica, Milani, Martina, Di Poi, Emma, Airò, Edoardo, Metra, Marco, Garascia, Andrea, Sinagra, Gianfranco, Lo Giudice, Francesco

“…Risk scores are important tools for the prognostic stratification of pulmonary arterial hypertension (PAH). Their performance and the additional impact of…”
Get full text

Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype by Toma, Matteo, Savonitto, Giulio, Lombardi, Carlo Maria, Airò, Edoardo, Driussi, Mauro, Gentile, Piero, Howard, Luke, Moschella, Martina, Di Poi, Emma, Pagnesi, Matteo, Monti, Simonetta, Collini, Valentino, D'Angelo, Luciana, Vecchiato, Veronica, Giannoni, Alberto, Adamo, Marianna, Barbisan, Davide, Bauleo, Carolina, Garascia, Andrea, Metra, Marco, Sinagra, Gianfranco, Giudice, Francesco Lo, Stolfo, Davide, Ameri, Pietro

“…To obtain real-world evidence about the features and risk stratification of pulmonary arterial hypertension (PAH) with a left heart disease (LHD) phenotype…”
Get full text

Etanercept in Rheumatoid Arthritis by Cook, D A, Dimick, J B, Gallagher, D C

“…To the Editor: The study by Weinblatt et al. (Jan. 28 issue) 1 attempts to demonstrate the efficacy of combined therapy with methotrexate and etanercept…”
Get full text

Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension by Savonitto, Giulio, Barbisan, Davide, Ameri, Pietro, Lombardi, Carlo Maria, Monti, Simonetta, Driussi, Mauro, Gentile, Piero, Howard, Luke, Toma, Matteo, Pagnesi, Matteo, Collini, Valentino, Bauleo, Carolina, Adamo, Marianna, D'Angelo, Luciana, Nalli, Chiara, Giannoni, Alberto, Vecchiato, Veronica, Di Poi, Emma, Airo, Edoardo, Metra, Marco, Garascia, Andrea, Sinagra, Gianfranco, Lo Giudice, Francesco, Stolfo, Davide

“…Aims The use of loop diuretics in pulmonary arterial hypertension (PAH) is less frequent compared with heart failure. The clinical and prognostic…”
Get full text